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Abstract
Background: MicroRNAs (miRNAs) are small endogenous non-coding RNAs that control genes at post-transcriptional
level. They are essential for development and tissue differentiation, and such altered miRNA expression patterns are
linked to the pathogenesis of inflammation and cancer. There is evidence that miRNA expression is genetically
controlled similar to the transcription of protein-coding genes and previous studies identified quantitative trait
loci (QTL) for miRNA expression in the liver. So far, little attention has been paid to miRNA expression in the skin.
Moreover, epistatic control of miRNA expression remains unknown. In this study, we characterize genetic regulation of
cutaneous miRNA and their correlation with skin inflammation using a previously established murine autoimmune-
prone advanced intercross line.
Results: We identified in silico 42 eQTL controlling the expression of 38 cutaneous miRNAs and furthermore found two
chromosomal hot-spots on chromosomes 2 and 8 that control the expression of multiple miRNAs. Moreover, for 8
miRNAs an interacting effect from pairs of SNPs was observed. Combining the constraints on genes from the statistical
interaction of their loci and further using curated protein interaction networks, the number of candidate genes for
association of miRNAs was reduced to a set of several genes. A cluster analysis identified miR-379 and miR-223 to be
associated with EBA severity/onset, where miR-379 was observed to be associated to loci on chromosome 6.
Conclusion: The murine advanced intercross line allowed us to identify the genetic loci regulating multiple miRNA in
skin. The recurrence of trans-eQTL and epistasis suggest that cutaneous miRNAs are regulated by yet an unexplored
complex gene networks. Further, using co-expression analysis of miRNA expression levels we showed that multiple
miRNA contribute to multiple pathways that might be involved in pathogenesis of autoimmune skin blistering disease.
Specifically, we provide evidence that miRNA such as miR-223 and miR-379 may play critical role in disease progression
and severity.
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Background
The discovery of microRNAs (miRNAs), a class of small
endogenous non-coding molecules ranging from 18–24 nt
brought a new level of complexity for understanding the
mechanisms that constitute various biological processes
[1, 2]. The involvement of miRNAs in the control of gene
expression has been thoroughly defined for the cell cycle,
metabolism, and immune system and in cancer [3–6].
Binding to the 3′ or 5′ UTR region of genes, miRNAs
may yield increased or decreased gene expression levels
and have been described to affect various molecular path-
ways [7].
Approximately half the miRNAs are intergenic with
few also located in intronic regions [8, 9]. These are
understood to have their own enhancers and promoters
and are transcribed by RNA polymerase II [10]. How-
ever, it remains unclear whether these are produced as
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by-products of protein-coding gene transcription or
whether their biogenesis has its own machinery [11].
Recent studies in murine and human fibroblasts of liver
tissues revealed that miRNA expression can either be
regulated by their transcriptional genomic location or
by other regions in the genome [12]. Furthermore, mu-
tations in genes involved in miRNA processing, such as
AGO1, DGCR8, and DICER, can cause significant changes
in the expression of miRNAs, resulting in altered disease
susceptibility [13]. Regarding the skin, in vivo studies show
that miRNA biogenesis is dependent on both DICER and
DGCR8. A lack of these enzymes causes severe pheno-
types [14], underscoring the importance of miRNAs in the
regulation of morphogenesis and homeostasis of the skin
[15]. Differentially expressed miRNAs are associated with
different physiological and pathological processes in the
skin such as melanoma, Sézary syndrome, psoriasis and
atopic dermatitis [16–19]. Advancements have been
achieved in understanding various processes regulated
by miRNAs. On the other hand, the mechanisms that
regulate their own expression have so far remained un-
known. One possible approach towards understanding
their regulation is constraining on genetic loci whose
variations statistically link the variable phenotypic effect.
We thus performed an in silico expression QTL-based
analysis, which has been widely used for deciphering gen-
etic loci regulating gene expression in various biological
processes [20]. Su et al. have further shown that expres-
sion QTL-based analysis can provide insights into miRNA
regulation [12]. However, no study has yet been performed
to determine the impact of genetic variation on miRNAs
associated to skin and autoimmune disorders.
This study (i) uses expression QTL-based analysis to
define genetic loci that control miRNA expression in the
skin and (ii) provides insights into interacting genes to
control a single transcript (epistasis). The relevance of
these findings is illustrated by employing a mouse model
for the autoimmune blistering disease EBA (Epidermolysis
Bullosa Acquisita), providing a direct link between miRNA
expression and disease phenotype. Taken together, the
data provide insights into the complexity of miRNA
regulation and possible means to understand various
gene interactions altering the expression of miRNAs.
Results
A murine heterogeneous inter-cross line was generated
by inter-crossing four parental inbred mouse strains:
MRL/MpJ, NZM2410/J and BXD2/TyJ as autoimmunity-
prone strains and Cast/EiJ for genetic heterogeneity. As a
mouse model for an autoimmune blistering disease, 100
mice from generation 4 of the intercross-line were immu-
nized with recombinant collagen type VII (COL7), an
integral component of anchoring fibrils located at the
dermal-epidermal junction. This induced a loss of
tolerance and production of anti-COL7 autoantibodies
in all immunized mice. The incidence of sub-epidermal
blisters and the clinical phenotype of epidermolysis bul-
losa acquisita (EBA) were at 1/3 [21]. All mice were ge-
notyped and miRNA expression profiling was acquired
from skin tissue using the Affymetrix’s GeneChip miRNA
2.0 array. To reveal genetic loci that regulate miRNA
expression, we then performed an association study be-
tween the genotype and the respective expression levels
of miRNAs. Further we performed co-expression analysis
between expression levels of miRNAs and phenotype. The
workflow is presented in a flowchart (Additional file 1:
Figure S1).
miRNA expression is genetically controlled
We performed a genome-wide scan to detect genetic loci
associated with miRNA expression. Expression levels of
miRNA were treated as quantitative trait to yield expres-
sion quantitative trait loci (eQTL). Genome-wide signifi-
cance was determined by a permutation test. Using an
E-value cutoff of <0.05, 42 eQTL for 38 miRNAs were
mapped to the genome, corresponding to 6.83 % of all
murine miRNAs present on the above mentioned Affy-
metrix GeneChip (Table 1 and Fig. 1). Since the wild
derived strain CAST/EiJ was incorporated into the ad-
vanced intercross line, we investigated the polymorphic
sites located in the transcribed miRNAs that may have
an effect of probe hybridization which is derived from
C57B6/J [22]. We obtained the SNPs and indels in gen-
ome of CAST/EiJ from the database [23]. We found
that 4/38 (10.53 %) miRNAs (miR-291a-3p, miR-341,
miR-449b and miR-681) exhibits indels in CAST/EiJ
strain on chromosome 7 (3.2 Mb), 12 (69 and 109 Mb)
and 13 (113 Mb), which may suggest false positive asso-
ciations for those loci (Table 1). The highest -log P value of
6.57 was observed for miR-298 on chromosome 9 explain-
ing 20.76 % of the variance. The peak SNP (rs3700596)
was found within 1 kb of the Ube3D gene, an ubiquitin-
conjugating enzyme E2c binding protein. We found only
trans – eQTL, except for miR-486 (−log P = 4.10,
rs13479880), which was mapped to the same chromosome
of its transcriptional site (Chr 8, ~89 Mb). This indicates
that other genes rather than their own transcript may con-
tribute to the regulation of miRNA expression which could
be tissue specific.
Prior knowledge suggests classes of gene families that
play a major role in the regulation of miRNA expression
i.e. Argonaute proteins and helicases which play a cru-
cial role in its regulation [24]. To examine this assump-
tion, we obtained the coordinates of all helicases and
other genes involved in pathways of miRNA biogenesis
from ‘The RNA Helicase Database’ and mapped them to
the eQTL identified in our study [25]. Helicases like
Ddx39, Ddx49, Cd97 and Upf1 were mapped within the
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Table 1 eQTL detected for the expression of miRNA
AffyID PEAK SNP Chr Pos(Mb) CI -logP score α Transcript Location (Chr:Pos)
miR-322 rs6386920 1 54.1 51.5–58.4 4.797697778 0.02 X:50407432-50407526
miR-431 rs6386920 1 54.1 51.5–59.8 5.231417376 0.006 12:110828657-110828747
miR-26a rs6265423 2 47 28.1–51.3 4.376166299 0.021 10:126432586–126432669,9:118940914-118941003
miR-291a-3p CEL.2_50605053 2 50.5 28.1–59.9 4.546953451 0.018 7:3218920-3219001
miR-423-3p rs6265423 2 47 33.9–51.3 4.948513523 0.015 11:76891566-76891674
miR-671-5p rs13476472 2 45.5 33.9–50.5 5.838570402 0.004 5:24097932-24098029
miR-23b rs6250599 2 48.5 44.3–51.3 4.335454904 0.022 13:63401792-63401865
miR-409-5p rs13476874 2 159.5 136–163 4.175101842 0.035 12:110981368-110981446
miR-409-5p rs13477083 3 43.3 27.5–45.4 4.215972522 0.033 12:110981368-110981446
miR-546 rs13477126 3 56.4 52.9–58.3 4.493016911 0.029 10:126435496-126435616
miR-200a-star rs3671119 3 126.1 117.4–131.3 4.688008826 0.011 4:155429005-155429094
miR-339-5p rs3660863 4 7.1 3.7–19.5 4.878132165 0.003 5:139845604-139845699
miR-465c-5p rs13477873 4 101.1 82.8–118 4.472478928 0.01 X:64079130-64079210
miR-295 rs3663950 4 135.3 129.4–141.1 4.209508065 0.04 7:3220774-3220842
miR-878-3p rs13478002 4 136.2 135.3–141.1 5.110152979 0.01 X:64054683-64054760
miR-742 rs3673049 5 90.1 87.5–96.6 4.765858909 0.035 X:64033548-64033612
miR-379 rs6208251 6 104.8 98.4–116.7 4.024954772 0.034 12:110947270-110947335
miR-154 rs13479063 6 136.3 133.92–142.4 4.309450382 0.032 12:110976643-110976708
miR-425* rs3663988 7 146.5 140.2–146.5 4.342220512 0.035 9:108471108-108471192
miR-486 rs13479880 8 89.3 72.5–95.1 4.108040959 0.033 8:24253027-24253154
miR-487b rs6257357 8 88 77.7–90.2 4.81779528 0.019 12:110965543-110965624
miR-501-3p rs13479880 8 89.3 81.7–95 4.205948891 0.03 X:6818369-6818477
miR-130b rs6413270 9 37.7 36.8–44.4 4.222559895 0.032 16:17124154-17124235
miR-298 rs3700596 9 86.2 85–90.6 6.573678024 0.001 2:174093005-174093086
miR-466c-3p rs3712394 10 17.7 14.1–24.2 4.569565941 0.03 2:10403161-10403244
miR-466c-3p rs13480563 10 27.9 24.2–38.7 4.591526295 0.029 2:10403161-10403244
miR-126-5p rs6374078 10 60.6 30.7–65.9 4.177297455 0.031 2:26446877-26446949
miR-681 rs13481076 11 66.5 40.1–71.3 4.055742697 0.043 12:70864822-70864931
miR-20a-star rs3712881 11 120.9 112–121 4.160612966 0.03 14:115443379-115443485
miR-203 mCV22351241 12 60 55.0–72.6 3.838027866 0.039 12:113369091-113369166
miR-542-3p CEL.12_84750094 12 91.4 79.7–103.8 4.735149963 0.023 X:50402580-50402664
miR-341 gnf13.079.671 13 80.5 69.5–88.3 5.260091403 0.008 12:110849710-110849805
miR-449b rs13482231 14 67.6 50.9–72.3 4.485232377 0.019 13:113827627-113827706
miR-7a CEL.15_4222769 15 4.4 3.2–9.7 4.941341377 0.044 13:58494140–58494247, 7:86033163-86033259
miR-7a rs13482455 15 16.7 14.8–24.5 5.73214998 0.022 13:58494140–58494247, 7:86033163-86033259
miR-337-3p rs13482549 15 45.5 38.4–53.9 4.298224443 0.029 12:110823999-110824095
miR-673-5p rs13482549 15 45.5 38.9–56.6 4.592339382 0.014 12:110810200-110810290
miR-136 rs13482914 17 21 16.5–27.6 4.679083445 0.026 12:110833537-110833598
miR-466b-5p rs13483212 18 12.3 0–21 4.48515896 0.016 2:10395846-10395927
miR-493 rs6211533 19 57.1 50.2–60.2 4.98913787 0.004 12:110818443-110818525
miR-26a gnfX.023.543 X 36.3 0–49.3 4.718906745 0.01 10:126432586–126432669, 9:118940914-118941003
miR-466e-5p rs13483712 X 9.1 0–33.5 4.013512497 0.05 2:10398257-10398340
AffyID Affymentrix ID, Chr Chromosome, Pos (Mb) Peak Position SNP in Mb, CI Confidence Interval (CI) in Mb using 1.5 -log P drop, α Genome wide significance
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confidence interval of miR-486, miR-487b and miR-501
on chromosome 8. Further, four helicases (Ddx50, Ascc3,
Ddx21 and Dna2) were mapped within the confidence
interval of the eQTL controlling miR-126. Genes that
are involved in transcriptional processes, such as Polr3f,
Polr2a, Polr3g and Polr2a were also mapped to the
eQTL for miR-409, miR-681, miR-34 and miR-449.
Other genes which do not belong to these classes, such
as lin28a and its homolog lin28b, have been shown to
modulate let-7a [26]. These genes were mapped to the
eQTL for miR-290 on chromosome 4 and miR-126 on
chromosome 10, suggesting that Lin28 might modulate
the expression of other miRNAs as well.
Some miRNA eQTL were constrained to a specific lo-
cation in the genome, thereby suggesting potential eQTL
hotspots for the regulation of multiple miRNAs. On
chromosome 2, five miRNAs (miR-26a, mir-291a, miR-423,
miR-671 and miR-23b) were mapped between 28–51 Mb
(Fig. 2). Three nearby SNPs (rs6250599 ~ 48.5 Mb,
rs6265423 ~ 47 Mb and rs13476472 ~ 45 Mb) showed sig-
nificant association (−log P > 4) with all five miRNAs that
were mapped to this region. A long non coding RNA
1700019E08Rik was located near SNP rs13476472 (~3 Kb
upstream). As for the other two SNPs, the nearest gene to
rs6265423 was mapped 6.8 kb apart, coding for the snRNA
U7.39-201, while the nearest coding gene for SNP
Fig. 1 Transcriptome map for eQTL of miRNA . The x-axis in the figure represents the SNP location in the chromosome, and the y axis represents
the transcriptional site of miRNAs. In this figure genome wide significant threshold of α < 0.25 is represented in a green. 83 miRNA eQTL were
defined as suggestive eQTL for miRNA (genome wide threshold, α < 0.1) are represented in blue. 43 miRNA eQTL with α < 0.05 were observed
as significant eQTL are represented in red
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rs6250599 was a pseudogene Gm13489-001 (~13 kb
upstream).
Similarly, on chromosome 8 we identified eQTL for
three miRNAs (miR-486, miR487b and miR-501) in con-
fidence interval 72–95 Mb. Three genes Gm1068, Siah1
and Dnaja2 were located near peak SNPs (rs13479880
and rs6257357).
Furthermore, we found several miRNAs that are asso-
ciated to more than one locus in the genome. For example
miR-7a showed significant association with two loci
present on chromosome 15 (3–9 Mb, CEL.15_4222769
and 14–24 Mb, rs13482455). Similarly, miR-466-3c was
regulated by two nearby loci on chromosome 10 (14–
24 Mb, rs3712394 and 24–38 Mb, rs13480563). Addition-
ally, miR-26a was mapped with two loci on chromosomes
2 and X (28–51 Mb, rs6265423 and 0–49 Mb,
gnfX.023.543).
Epistatic control of miRNA expression
A defective of single loci may possibly be compensated
by another, or only jointly the effect is the strongest.
Therefore, for all the miRNAs significant single-locus
eQTL, we analyzed the epistatic effect for each SNP pair.
As a result, we identified 200 SNP pairs for 8 miRNAs
below the significance level (adjusted P value < 0.05)
(Fig. 3 and Additional file 1: Table S1). The highest -log
P value of 10.38 was found between the SNP pairs
rs13480360 (chr 10, ~67 Mb, nearest gene: AK139516)
and rs3689658 (chr 2, ~ 85 Mb, nearest gene: Olfr1006)
for miR-7a (Table 2). In total, we found 119 SNP pairs
for miRNA miR-7a. The hub locus (i.e. SNP with the
maximal number of interactions) for miR-7a was ob-
served on chromosome 16 (rs3680665 ~ 84 Mb, nearest
gene: AK04263). The same SNP (rs3680665) also showed
association with miR-542 additionally with another SNP
(rs4200124, nearest gene: Gbe1) present nearby. For
miR-742 we observed 47 SNP pairs with SNP rs3657112
(~148 Mb, nearest gene: Snora17) on chromosome 3
showing the highest number of associations (40 SNP
pairs). The same SNP i.e. rs3657112 also showed statis-
tical interaction with chromosome 9 loci 67–72 Mb for
miR-295. We also found multiple SNPs on chromo-
some 2 (13–17 Mb) statistical interacting with SNPs
on chromosome 1(3–11 Mb) for miR-501. Two miRNAs
(miR-136 and miR-337) had only one significant SNP pair:
for miR-136 the correspondence was found between SNPs
rs37113033 (chr 19, ~5 Mb, nearest gene: Slc29a2) and
rs13459176 (chr 15, ~3 Mb, nearest gene: Sepp1), while
Fig. 2 eQTL hot spots on chromosome 2. Position on x axis represents the coordinates in million base pairs on chromosome 2. The y axis is –log
P value. The overlapping peaks on y axis represents an eQTL hot spot between 28–51 Mb. miR-181, miR-30b* and miR-874 are additional suggestive
eQTL with significant genome-wide (α < 0.1) threshold after permutation
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miR-337 had SNP pair rs3693942 (chr 13, ~55 Mb, nearest
gene: Unc5A) and rs3663950 (chr4, ~135 Mb, nearest gene:
Il22ra) (Table 2).
To search the candidate interacting gene pairs we in-
vestigated the epistatic control of miR-501-3p. Using the
Ingenuity pathway analysis (IPA), we searched for all the
possible interacting genes present between loci present
on chromosome 1 and chromosome 2 [27]. We found
three putative interacting gene pairs; namely Commd3
with Cops5, Cacnb2 with Vopip1 and Commd3-Bmi1
with Rb1cc. Interestingly, Cops5 in the Nfkb1 pathway
possibly be associated with miR-501 via Tp53 (Additional
file 1: Figure S2).
Genetic overlap of QTL for clinical scores and miRNA
expression
Any genetic variation with an effect on the clinical pheno-
type and miRNA levels should map to the same chromo-
somal region. Previously, genetic loci for the clinical
phenotype of EBA, an autoimmune skin blistering disease,
Fig. 3 Epistasis in miRNA eQTL. The circular plot shows the chromosomes in their circumference. Each connecting line represents a SNP pair
interaction above the significance level (adj. P < 0.05). Each interaction is color coded for different miRNAs. The boxes adjacent to the chromosomal
band show eQTL for miRNAs mapped for single locus scans
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were studied using a larger cohort of mice from the same
breeding scheme. Previously, we mapped the QTL for the
onset of EBA to chromosomes 9 (39.5–46.3 Mb), 12
(83.2–109.9 Mb), 14 (49.1–68.9 Mb) and 19 (46.0-end Mb).
Additionally, three QTL were mapped for severity of EBA
on chromosomes 1 (3.1–27.3 Mb), 15 (61.0–85.7 Mb) and
19 (43.1-end Mb) [21]. In this study, we found 4 eQTL for
miRNAs overlapping with the QTL for EBA (Fig. 4). The
eQTL for miR130b (Chr 9: 36–44 Mb, −log P = 4.42),
miR-542-3p (Chr 12: 79–103 Mb, −log P = 4.73) and
Table 2 Epistasis in miRNA. The table includes only the top interacting SNPs for each miRNAs
miRNA Top interacting SNP 1 Top interacting SNP 2 I.Pval(log)
SNP ID chr Pos(Mb) Refseq Genes Pval(log) SNP ID chr pos(Mb) Refseq Genes Pval(log)
miR-7a rs13480630 10 67.29 0.89 rs3689658 2 85.52 Olfr1006 1.12 10.4
miR-136 rs3713033 19 5.03 Slc29a2 0.073 rs13459176 15 3.23 Ccdc152, Sepp1 1.56 7.2
miR-154 rs3708073 8 124.28 Gm20388,Jph3 0.3 rs8246404 2 136.7 Mkks 0.57 7.67
miR-295 rs13480271 9 72.68 RP23-461P14 0.018 rs3657112 3 148.03 0.32 8.064
miR-337-3p rs3693942 13 55.05 Unc5a 0.026 rs3663950 4 135.29 Il22ra1 0.2 7.17
miR-501-3p CZECH-2_15618849 2 15.5 Gm13364 1.33 rs3716083 1 9.01 Sntg1 0.72 8.46
miR-542-3p rs4200124 16 70.7 1.12 rs3718776 5 150.4 Wdr95 0.14 8.5
miR-742 rs3657112 3 148.028 0.35 CEL.1_49993068 1 49.68 0.33 9.16
Chr Chromosome, Pos (Mb) Position in million base pairs, Pval(log) Additive log 10 P value, I.Pval(log) Interacting log 10 P value
Fig. 4 Overlapping QTL for EBA disease and miRNA eQTL. The circular plot shows all the eQTL for miRNAs (green) and QTL for EBA (red). It also
presents the eQTL hot spots (dark green) and EBA QTL for onset (red) and severity (dark red). Each circular band represents a chromosome on
which QTL and eQTL are mapped. The region within the chromosome which has either red or dark red and green or dark green bands is
overlapping eQTL with EBA QTL
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miR-449b (Chr 14: 50–72 Mb, −log P = 4.49) were
mapped on QTL for disease onset on chromosome 9,
12 and 14. Additionally, we mapped eQTL for miR-493
(50–60 Mb, −log P = 4.98) to the QTL for both disease
severity and onset on chromosome 19. To further
evaluate, if the variation in the genome is associated
with the miRNA expression levels and also underlies
the clinical phenotype, we investigated the genotype as-
sociation of significant SNPs of miRNA eQTL with
clinical phenotype (Fig. 5). We observed that the most
significant SNP (rs6211533) mapped for the eQTL of
miR-493 on chromosome 19 also shows variation for
EBA severity score and onset. In this eQTL minor allele
(BB) derived from MRL/MpJ was associated with higher
expression of miR-493, late onset of the disease, and
higher clinical score (Fig. 5b). Similar observation was
also derived for eQTL mapped (peak SNP, rs6413270) for
miR-130b where minor allele (BB) derived for MRL/MpJ
and NZM/2410J was associated with lower expression of
miR-130b, and late onset of disease phenotype (Fig. 5a).
Fig. 5 Boxplot for genotype variations for significant SNP in miRNA eQTL for disease QTL. The figure describes the genotype variation for the
peak SNP for miRNAs mapped to the previously described EBA QTL. a) In miR-130b eQTL, peak SNP (rs6413270, −logP = 4.22) have genotype AA
for BxD2 and CAST/EiJ while BB for NZM/2410J and MRL/MpJ strain. The variation associated with three genotypes AA, AB and BB for expression
of miR-130b is presented on left and onset week of EBA on right box. b) In miR-493 eQTL, peak SNP (rs6211533, −logP = 4.99) have genotype AA
for BxD2, CAST/EiJ and NZM/2410J while BB for MRL/MpJ strain. The variation associated with three genotypes AA, AB and BB for expression of
miR-493 is on left, maximum score of severity of EBA disease in middle and onset week of EBA on right
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Expression and co-expression of miRNAs
Immunization of mice with recombinant COL7 leads to
development of subepidermal blisters and the clinical
phenotype of EBA in 1/3 of the immunized mice, while
2/3 remain clinically healthy. To access differential ex-
pression of miRNAs, we divided the 4th generation of
our mouse cohort into two separate groups: affected and
non-affected mice. Comparing the two groups, only
two miRNAs were differentially expressed: miR-379
(adj. P value = 0.044) and miR-223 (adj. P value = 0.044)
(Fig. 6 and Additional file 1: Table S2). Both miRNAs
were significantly over expressed in mice with disease.
Additionally, an eQTL for miR-379 (−log P = 4.7, 98–
116 Mb) was also mapped on chromosome 6, with its
peak at ~104 Mb (rs6208251, nearest gene: Cntn6).
The comparison of diseased and non-diseased mice
has its drawbacks; the disease severity observed for indi-
vidual mice might differ depending on the differences in
the genome. To investigate miRNA expression affecting
disease severity, we performed co-expression analysis
among the expression levels of miRNAs (co-expressed
miRNAs are in same pathway) in correlation with quan-
titative scores for severity and onset week of disease. For
this purpose, we employed the WGCNA R package, which
clusters miRNAs into different modules and further asso-
ciates them to a phenotypic score, such as EBA severity or
disease onset. As a result, we identified 11 clusters (Fig. 7).
Using this approach, only the ‘black’ module, consisting of
23 miRNAs, was significantly associated with EBA (ρ =
0.28, P = 0.005) (Additional file 1: Table S3). Additionally,
it was significantly correlating to the onset of EBA (ρ =
0.29, P = 0.005). Due to the fact that the ‘black’ module
stronger correlates with the onset of the disease than with
the maximum score, one can speculate that miRNAs from
this module is rather involved in the onset than in the se-
verity of the disease. This would relate to our previous ob-
servation, in which miRNA eQTL were overlapping with
EBA onset QTL. The pathways associated with the ‘black’
module were predominantly pathways which have been
shown to play a crucial role in other autoimmune disor-
ders, such as the MAPK signaling pathway, T-cell receptor
and TGF-beta (Table 3).
Individual correlation of miRNA expression levels with
the disease severity identified 24 miRNAs to be significant
(P < 0.05) (Additional file 1: Table S3), with miR-223
showing the strongest association (ρ = 0.4, P = 4.93e-05).
To further validate this result we experimentally verified
the expression of miR-223 in EBA skin by qRT-PCR. We
found that miR-223 is upregulated in EBA skin in com-
parison to normal skin (Additional file 1: Figure S3). An-
other miRNA which was highly correlating with EBA was
miR-21 (ρ = 0.36, P = 0.00036). Further, investigations of
the co-expression module showed that miRNAs were po-
tentially co-regulated i.e. possible overlapping genetic loci
among co-expressed miRNAs. We observed that miRNAs
in a given locus were either clustered within the same
Fig. 6 Boxplot showing differentially expressed miRNAs. The box plot shows the most differentially expressed miRNAs miR-223 and miR-379 for
the disease phenotype EBA. The plots in blue color show the expression of miRNAs in mice with no clinical phenotype while mice with signs of
inflammation are shown in red
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module or showed stronger inter-module membership for
a specific module even if they were assigned to different
modules. As an example, miR-322 and miR-431, that
were mapped on chromosome 1 (51–59 Mb), are clus-
tered in the ‘red’ module. In eQTL hot spots as on
chromosome 2 (28–51 Mb), miR-423-3p and miR-23b
are clustered in the ‘yellow’ module. Even though other
miRNAs in this locus were assigned to a different mod-
ule, they also show significance for the ‘yellow’ module.
Examples are given by miR-671-5p (P = 1.224713e-12),
miR-26a (P = 2.654271e-19) and miR-291a-3p (P =
3.530522e-02) (Additional file 1: Table S3). In line with
this observation, for the eQTL mapped on chromosome
8, two miRNAs (miR-501-3p and miR-486) were clus-
tered with the ‘brown’ module while miR-487 was as-
signs to the ‘red’ module but had significant module
membership with the brown module as well (P = 0.004).
Thus, these genomic loci may be considered as con-
firmed and strengthen the genetic contribution for the
control of miRNAs expression levels.
Discussion
Small non-coding RNAs like miRNAs are known to con-
tribute to the onset and severity of various diseases as
well as the defense against them [28]. Thus, miRNAs
function as tissue-specific key regulators, affecting some
of the major pathways towards an aggravation of disease
severity when aberrantly expressed [29]. Accordingly, it
is not of surprise that miRNAs have been recently recog-
nized as potential therapeutic targets [30, 31].
However, the underlying mechanisms of such dysregu-
lated miRNA expression patterns are not well character-
ized. Different studies have shown that gene expression
alterations in different tissues are genetically derived [29].
Thus, it is plausible that not only the regulation of gene
expression is genetically controlled, but also the expres-
sion of miRNAs. In this study we explore the diversity of
miRNAs in inflamed skin tissue and genetic loci that con-
trol variations in miRNA expression levels across a mouse
cohort. We provide evidence that miRNA levels in skin
tissue are genetically controlled on transcriptional level by
helicases and RNA polymerases that are important for the
biogenesis of miRNA. Furthermore, we found that some
of the miRNA eQTL are restricted to one particular locus
in the genome (eQTL hot spots). Deeper investigation re-
vealed that these miRNAs are under multi-locus and/or
epistatic control.
Interestingly, eQTL hot spots were predominantly
found in genomic regions coding for non-coding RNA.
Hence, it is tempting to speculate miRNA expression
might not necessarily be solely controlled by protein-
coding RNA, but rather by non-coding RNA which
would impose an additional level of post-transcriptional
regulation. This in turn leads to the tempting hypothesis
that non-coding RNAs do at least in part regulate
miRNA expression. Such a scenario is supported by the
fact that some non-coding RNAs have been shown to
r
Fig. 7 Module-trait relationship between clusters of miRNAs with EBA severity and onset. The graph is a representation of co-expression analyses
of miRNAs. The clusters of miRNAs are called modules which are color coded on the y-axis. The disease phenotypes (traits) are EBA onset and EBA severity
given on the x-axis. Blocks represent the correlation of module with phenotype using a Pearson correlation coefficient ranging from −1 to 1. The range is
color coded with red representing positive correlation and blue representing negative correlation. P values are given in brackets below the
correlation coefficients
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bind to miRNAs at functional level as demonstrated by
an interaction of linc-MD1 with miR-133 and miR-135
[32]. Here, linc-MD1 works as a sponge and traps these
miRNAs preventing the binding to the canonical targets.
Moreover, a recent study even shows an interaction net-
work between lncRNAs and miRNAs [32].
Based on our observed overlap between QTL control-
ling miRNA expression and EBA, a blistering phenotype
in autoimmune skin disease, we conclude that there are
interconnected pathways to simultaneously regulate both
disease development and miRNA expression. This might
explain the findings of earlier studies that show a clear
correlation of aberrant miRNA expression and auto-
immune diseases [33–36]. Accordingly, initiation and/or
progression of the disease do not primarily appear to be
caused by aberrant miRNA expression. Quite the con-
trary seems to be true; aberrant miRNA expression
could be a consequence of the disease which in turn
would lead to a downward spiral. Hence, miRNAs could
provide a large and unexplored reservoir of potential
biomarkers for EBA and related cutaneous autoimmune
skin blistering diseases and an interesting target for
therapeutic intervention.
Conclusion
Taken together, our study provides a complex framework
of gene-gene and miRNA-gene-interactions, which even-
tually leads to disease development and progression.
Our data provide evidence that miRNAs are important
drivers of cutaneous autoimmune diseases by acting on
various pathways. Moreover, the study strongly implies
there is yet another, so far largely unexplored level of
regulatory network, possibly comprised of by non-
coding RNAs which on their part affect miRNA expres-
sion. In this sense, aberrant miRNA expression would
indeed be one the responsible elements for disease pro-
gression, however, the driving force behind might be a
different one.
Methods
Generation of a 4-way advanced intercross line
The out bred four-way autoimmune-prone advanced
intercross line (AIL) was generated (in our group) from
the parental mouse strains BXD2/TyJ, MRL/MpJ,
NZM2410/J and CAST/EiJ [21, 37, 38]. All strains were
purchased from The Jackson Laboratory (Bar Harbor,
ME). The four inbred strains were intercrossed following
Table 3 List of over-represented KEGG pathways for ‘black’ module
Total Genes of the Term Union Targets in the Term Union miRNAs in the Term Score
AXON_GUIDANCE 131 51 17 1.88
PATHWAYS_IN_CANCER 323 98 18 1.788
MAPK_SIGNALING_PATHWAY 271 89 17 1.69
NEUROTROPHIN_SIGNALING_PATHWAY 131 45 16 1.557
T_CELL_RECEPTOR_SIGNALING_PATHWAY 109 42 16 1.424
ENDOCYTOSIS 219 65 16 1.408
TGF-BETA_SIGNALING_PATHWAY 85 30 15 1.334
GLIOMA 65 27 16 1.319
PROSTATE_CANCER 89 32 17 1.314
UBIQUITIN_MEDIATED_PROTEOLYSIS 138 52 16 1.277
COLORECTAL_CANCER 65 25 16 1.271
WNT_SIGNALING_PATHWAY 153 38 18 1.268
MELANOGENESIS 100 34 18 1.256
ERBB_SIGNALING_PATHWAY 87 33 17 1.246
MTOR_SIGNALING_PATHWAY 53 22 13 1.154
INSULIN_SIGNALING_PATHWAY 137 45 16 1.151
B_CELL_RECEPTOR_SIGNALING_PATHWAY 76 23 16 1.137
FOCAL_ADHESION 197 50 18 1.111
ADHERENS_JUNCTION 74 28 17 1.097
CHAGAS_DISEASE 102 34 16 1.094
GNRH_SIGNALING_PATHWAY 99 32 15 1.042
MELANOMA 71 26 16 1.037
PANCREATIC_CANCER 70 27 15 1.028
ENDOMETRIAL_CANCER 52 19 16 1.022
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an equal strain and sex distribution. First generation
(G1) offspring mice were then mated based on their par-
ental origin to generate G2 mice in order to maintain an
equal distribution of the original strain alleles across the
genome. The same procedure was applied for intercross-
ing G2 and G3 mice. At least 50 breeding pairs were
used for each successive generation of mice. Animals
were held under pathogen free conditions at a 12-h
light/dark cycle with food and water ad libitum. All ani-
mal experiments were approved by the Ministerium für
Energiewende, Landwirtschaft, Umwelt und ländliche
Räume des Landes Schleswig Holstein in Kiel, Germany
(Refrence number : V 312–72241. 122–5 (12-2/09)).
Induction of experimental EBA
Experimental EBA was induced by immunization with
an immune-dominant peptide within the murine NC1
domain of Collagen type VII (GST-mCOL7C) as previ-
ously described [39]. In total, 600 mice of the AIL were
immunized out of which 100 mice were randomly se-
lected for miRNA expression profiling. Mice were evalu-
ated every 4th week after immunization regarding their
development and extent of skin disease, following an
established scoring system for a total period of 12 weeks
[40]. Murine skin tissues were obtained for analysis at
the end of the experiment.
Expression profiling and statistical analysis
Total RNA was extracted from skin tissue and processed
as previously described using the Flash Tag Biotin HSR
RNA labeling kit and hybridized with the miRNA ex-
pression profiling GeneChip miRNA 2.0 Array according
to the manufacturer’s protocol [41]. Raw data was pre-
processed using R packages and normalized using RMA
(Robust Multi-array analysis) to generate expression
levels across the samples following instruction of at bio-
conductors.org [42].
Genotyping and expression QTL analysis
Genomic DNA was isolated from tail clippings and in-
cubated in 500 μl 50 mM NaOH at 95 °C for 2 h. The
reaction was neutralized by posterior addition of 50 μl
1 M Tris HCl (pH 8.0). DNA was further processed
with DNeasy Blood & Tissue Kit according to manufac-
turer’s instructions. The extracted DNA was quantified
using Nanodrop and normalized to 50 ng/μl in TE buf-
fer (10 mM Tris; 1 mM EDTA; pH = 8). Agarose gel
electrophoresis was performed for quality control. A
total of 1400 SNPs markers evenly spaced across 19 au-
tosomes and the X chromosome were genotyped on
100 generation 4th mice using Illumina mouse medium
density array. 200 SNPs were discarded as they were
non informative and 1200 markers were retained. The
marker order and position in our map is provided in
(Additional file 1). The SNP genotype information for
each mouse from generation 4 and four founders is
provided in (Additional file 1). These informative SNPs
were used for performing eQTL analysis using HAPPY
2.3 on Debian Linux for miRNA expression levels [43, 44].
The software infers the haplotype probabilities for each
sample using the progenitor SNP information. The
miRNA expression levels of mice (600 probes) were
considered as quantitative traits and linkage analysis
with haplotype probabilities was done using the addi-
tive gaussian model. We considered gender as additive
covariate. 1000 permutations were performed across all
miRNA probes. A significant threshold (α = 0.05) was
defined genome-wide. Correction for family structure
was done using a variance component model: A Kinship
matrix was obtained by the EMMA R package to account
for relatedness among the individual [45] and interpreted
as a random effect with sex as fixed effect to perform sin-
gle marker association with phenotype.
We defined the confidence interval of the given eQTL
based on a -log P value drop of 1.5. We considered local
regulation if the eQTL for the probe was found on the
same chromosome as its genomic location. A trans-
regulation was presumed if the QTL controlling the trait
was found in a different chromosome than its genomic
location. The function “epistasis” from the HAPPY R
package was used to find pair wise SNP interactions
using F-score for the interaction model for SNPs which
were significantly associated with miRNA expression
levels in initial genomic scan [43]. All the P-values are
corrected for multiple testing using the Bonferroni cor-
rection. Circos was used for visualization of eQTL and
epistasis [46].
Co-expression analysis
The standard WGCNA procedure was used for module
detection [47]. For miRNA we considered 97 samples. 3
samples were excluded as these could not phenotype for
EBA score. A weighted adjacency matrix of pair-wise
connection strengths (correlation coefficients of gene ex-
pression levels) was constructed using the soft-threshold
approach with a scale independent topological power β =
7 (miRNA). For each probe, the connectivity was defined
as the sum of all connection strengths with all others.
Probes were aggregated into modules by hierarchical clus-
tering and refined by the dynamic cut tree algorithm [48].
The Pearson correlation coefficient was determined for
each phenotype-module pair. The representative module
expression profile, or module eigengene value, is the first
principal component of the gene expression profile within
a module. The correlation between the module eigengene
and the sample trait of interest yields the eigengene sig-
nificance, as assessed by a correlation test. The modules
were assigned by different colors where grey was assigned
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to traits that could not be clustered in any other mod-
ule. To determine the enriched pathways involved in a
cluster we used ‘miRsystem’ which uses the weighted
pathway-ranking method for identifying enriched bio-
logical functions [49].
Total RNA preparation, cDNA synthesis and qRT-PCR
Perilesional skin samples from mice injected with NC1
domain of Collagen type VII (GST-mCOL7C) or normal
skin from mice injected with GST alone were obtained.
Total RNA was extracted using TRIzol® reagent (Invitrogen
GmbH, Darmstadt, Germany). RNA concentrations were
measured on a Nanodrop 2000c spectrophotometer
(Thermo Fischer Scientific GmbH, Bremen, Germany).
Total RNA was used for cDNA synthesis as previously de-
scribed [50]. Briefly, 100 ng of total RNA were poly (A)
tailed and reverse transcribed in a single reaction tube con-
taining: 1 μl of 10xpoly(A) polymerase buffer, 0.1 mM of
ATP, 0.1 mM of dNTPs, 100 units of MuLV reverse
transcriptase (New England Biolabs, Frankfurt am Main,
Germany), 1 unit of poly(A) polymerase (New England
Biolabs, Frankfurt am Main, Germany), and 1 μM of RT
primer (5′-CAGGTCCAGTTTTTTTTTTTTTTTGT-3′)
in a final volume of 10 μl. Consequently, the tube was in-
cubated at 42 °C for 1 h followed by 5 min at 95 °C. The
cDNA was diluted 1:10 before the qPCR reaction. qPCR
analysis was performed on a Mastercycler ep Realplex
(Eppendorf AG, Hamburg, Germany) using 8 μl of diluted
cDNA, 10 μl of SYBR Select Master Mix (Thermo Fischer
Scientific GmbH, Bremen, Germany), and 250nM mmu-
mir-223 specific primer set. The cycling conditions were
50 °C for 2 min, 95° for 2 min, followed by 40 cycles of
95 °C 15 s and 60 °C for 1 min. The expression levels of
mmu-mir-223 were normalized against β-actin. The se-




TTG-3′; mmu-β-actin R: 5′- ACGACCAGAGGCATA
CAGG-3′.
Availability of the supporting data
Data is accessible at NCBI GEO GSE64276.
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Additional file 1: Figure S1. Flowchart describing the workflow of
analysis. The flowchart provides an overview of the analysis performed
for understanding regulation of miRNAs and their contribution to the
disease phenotype. Figure S2 Interaction network accessed via IPA software
for epistasis of miR-501. The graph depicts the interacting genes identified
from epistasis scan of miRNA miR-501 in chromosome 1 and chromosome 2.
The graph shows all known gene interactions between the two loci where
genes colored in yellow are from locus on chromosome 2 and green are
from locus on chromosome 1. The red line shows the possible pathway for
the regulation of miR-501. Figure S3 qRT-PCR validation of miR-223
expression in EBA and normal murine skin. (ZIP 637 kb)
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